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Abstract
Background: Short-term particulate air pollution exposure is associated with reduced heart rate variability (HRV), a
risk factor for cardiovascular morbidity and mortality, in many studies. Associations with sub-chronic or long-term
exposures, however, have been sparsely investigated. We evaluated the effect of fine particulate matter (PM2.5) and
black carbon (BC) exposures on HRV in an elderly cohort: the Normative Aging Study.
Methods: We measured power in high frequency (HF) and low frequency (LF), standard deviation of normal-to-
normal intervals (SDNN), and the LF:HF ratio among participants from the Greater Boston area. Residential BC
exposures for 540 men (1161 study visits, 2000–2011) were estimated using a spatio-temporal land use regression
model, and residential PM2.5 exposures for 475 men (992 visits, 2003–2011) were modeled using a hybrid satellite
based and land-use model. We evaluated associations between moving averages of sub-chronic (3–84 day) and
long-term (1 year) pollutant exposure estimates and HRV parameters using linear mixed models.
Results: One-standard deviation increases in sub-chronic, but not long-term, BC were associated with reduced HF,
LF, and SDNN and an increased LF:HF ratio (e.g., 28 day BC: −2.3 % HF [95 % CI:−4.6, −0.02]). Sub-chronic and
long-term PM2.5 showed evidence of relations to an increased LF and LF:HF ratio (e.g., 1 year PM: 21.0 % LF:HF
[8.6, 34.8]), but not to HF or SDNN, though the effect estimates were very imprecise and mostly spanned the null.
Conclusions: We observed some evidence of a relation between longer-term BC and PM2.5 exposures and changes
in HRV in an elderly cohort. While previous studies focused on short-term air pollution exposures, our results
suggest that longer-term exposures may influence cardiac autonomic function.
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Background
Particulate air pollution exposure is associated with
cardiovascular mortality and morbidity in a multitude of
epidemiologic studies, including at levels at or below
EPA standards [1, 2]. Pathways potentially mediating this
association include induction of systemic inflammation
[3, 4] and oxidative stress [5, 6], as well as changes in
ion channel function in myocardial cells [7] or cardiac
autonomic function [8–10].
Heart rate variability (HRV) is a marker of cardiac
autonomic control, which reflects autonomic modula-
tion of the rhythmic activity of the sinus node [11].
Reduced HRV is predictive of increased cardiovascular
morbidity and mortality risk [12, 13]. Short-term par-
ticulate air pollution exposure is associated with reduced
HRV in many epidemiologic studies, including a recent
meta-analysis [14] and within the current study popula-
tion [10, 15]. Associations are particularly pronounced
among the elderly [16], among those with preexisting
cardiovascular disease or diabetes [17], or among people
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with reduced antioxidative defenses [17, 18]. However,
the association between exposure to sub-chronic or
chronic air pollution exposure and HRV is unclear, al-
though long-term exposure is known to have a stronger
effect on cardiovascular mortality than acute exposure
[19]. Also, many previous studies have used air pollution
at a central site as the exposure metric, introducing
potential exposure error.
Particulate matter is a complex mixture of particles
and liquids, traffic and non-traffic components, and
varies in composition across geographic regions [1].
Studies to date suggest that traffic-related particulate
pollution may contribute significantly to cardiovascular
outcomes [17, 20], including changes in HRV [19].
In the current study, we used address-specific esti-
mates of exposure and evaluated whether sub-chronic
(3–84 day) and long-term (1 year) exposure to ambient
particulate matter <2.5 μm in aerodynamic diameter
(PM2.5) or black carbon (BC), a marker for traffic related
air pollution, would be associated with reduced HRV in
a cohort of elderly men. In addition to examining the
main effect of particulate air pollution on HRV, we also
evaluated potential modification by oxidative stress
allelic profile, hypertension, obesity and diabetes.
Methods
Study population
Our analysis included 540 men enrolled in the Veterans
Administration Normative Aging Study (NAS) who had
complete information regarding ambient BC concentra-
tions, HRV measures, and all covariates of interest, and
who underwent 1161 study visits between November 14,
2000 and August, 24, 2011. We also evaluated a largely
overlapping group of 475 participants with complete
information regarding PM2.5 concentrations and all co-
variates, who presented for 992 study visits between
January 14, 2003 and December 21, 2011. The NAS is a
prospective cohort study, described in detail previously
[21]. Briefly, this closed cohort was established in 1963
and enrolled 2280 adult male volunteers, free of chronic
medical conditions, who were living in the Greater
Boston area. Detailed questionnaires and physical exami-
nations were administered at all center-based study
visits, occurring every 3–5 years. Loss to follow-up has
been predominantly due to death or moving out of the
study area.
There were 727 active NAS study participants during
the time period of interest. Of these, 596 participants
had complete information regarding sub-chronic or
long-term residential BC exposures and HRV measures
for one or more study visits, and 540 had complete in-
formation regarding PM2.5 exposures and HRV measure-
ments. We excluded study participants with problematic
heart rate measurements from the analysis (as described
below, n = 56 for BC and n = 65 for PM2.5), which
brought the final sample size to 540 for BC and 475 for
PM2.5. Participants presented for 1–4 visits, with 65.6 %
(n = 354) undergoing at least two study visits for BC and
65.1 % (n = 309) for PM2.5.
Physical examinations included measurement of height
and weight, which was used to calculate body mass
index (BMI, in kg/m2). Blood samples were collected to
assess fasting blood glucose (FBG) levels. Smoking
history was obtained via an American Thoracic Society
questionnaire. Participants’ diabetes status was assessed
based on a physician’s diagnosis of type 2 diabetes, and/
or use or diabetes medication assessed during the phys-
ician interview. Similarly, hypertension was defined as a
measured systolic blood pressure (SBP) of ≥140 mmHg,
a measured diastolic blood pressure (DBP) of ≥90 mm
Hg, or participant use of anti-hypertensive medication.
SBP and DBP were measured by a physician, and mean
arterial blood pressure (MAP) was defined as DBP +
1/3(SBP-DBP). Finally, room temperature was recorded at
the time of electrocardiogram (ECG) measurement.
This study was approved by the Harvard School of
Public Health and Veteran Administration institutional
review boards, and all participants provided their written
informed consent.
To summarize, all participants were administered
questionnaires and were examined by a physician at each
study visit. These examinations included measurement
of heart rate variability, described below. Outdoor
temperature and residential air pollution exposure
estimates were also evaluated for several time periods pre-
ceding a participants’ study visit and are described below.
Heart rate variability
HRV was measured between 6:00 AM and 1:00 PM
using a two-channel, five-lead ECG monitor (Trillium
30,000; Forest Medical, East Syracuse, NY), as described
in detail previously [10, 22]. Briefly, participants rested
for 5 min, and then remained seated during the ECG,
which was recorded at a sampling rate of 256 Hz per
channel for approximately 7 min. Heart rate and HRV
measures were then calculated using PC-based software
(Trillium 3000 PC Companion Software for MS Windows;
Forest Medical, East Syracuse, NY) and reviewed by an ex-
perienced scanner to correct for any errors. The following
HRV measures were computed: high-frequency power
(HF; 0.15–0.4 Hz), low-frequency power (LF; 0.04–
0.15 Hz), LF:HF ratio, and the standard deviation of
normal-to-normal intervals (SDNN). HF is a marker of
parasympathetic drive, LF is a marker of both sympathetic
and para-sympathetic activity, and the LF:HF ratio reflects
the balance of sympathetic and para-sympathetic systems
and may also be influenced by baroreflexes. In contrast to
the latter frequency domain measures, SDNN is a time
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domain measure that reflects the variability in N-N inter-
val duration. As mentioned above, participants with prob-
lematic heart rate measurements (i.e., atrial fibrillation,
atrial bigeminy/trigeminy, pacemakers, irregular rhythm,
irregular sinus rhythm, frequent ventricular ectopic activ-
ity, ventricular bigeminy, multifocal atrial tachycardia, or a
measurement time of less than 3.5 min) were excluded
from our analysis.
Air pollution and weather
Daily BC exposures at participants’ residences in the
greater Boston area was estimated using a validated
spatio-temporal land-use regression model [23]. Daily
BC predictions were obtained using estimates averaged
from 148 monitoring sites, local meteorological condi-
tions, land use variables (including traffic density), day
of the week, and other factors [24]. Spatially-resolved
daily residential PM2.5 exposures were also estimated at
each residence using a validated hybrid exposure model,
which incorporated satellite based aerosol optical depth
(AOD) measurements as well as land-use and meteoro-
logical variables (i.e., outdoor temperature, elevation,
visibility, wind speed, distance to major roads, percent of
open space, traffic density, proximity to point emissions,
and area emissions). More in depth details can be found
in Kloog et al. [25].
For this study, we evaluated moving averages of pollu-
tant exposure at 3, 7, 21, 14, 28, 56 and 84 days as well as
1 year prior to each study visit. Specifically, we calculated
each participant’s average pollutant exposure level during
a given number of a days before each study visit. We also
calculated BC and PM2.5 levels 1 and 2 days prior to the
study visits, for use in sensitivity analyses.
Our regression models accounted for both room
temperature and outdoor temperature. Apparent tempera-
ture is defined as a person’s perceived outdoor temperature
in °C ([26, 27], and calculated using the following
formula: −2.653 + (0.994 * air temperature) + (0.0153 *
dew-point temperature)). We calculated moving aver-
ages of apparent temperature, corresponding to 1–28 days
before each study visit. Measured outdoor temperature
was also averaged during the two months, three months,
and one year preceding each study visit.
Oxidative stress genetic scores
Oxidative stress allelic profiles were calculated using a
genetic score approach [28], in which genetic variants
were selected using the least absolute shrinkage and
selection operator (Lasso) based on their relation to
8-hydroxydeoxyguanosine levels (8-OhdG, a marker of
oxidative DNA damage) [28]. The genetic variants used to
calculate oxidative stress score were CAT (rs1001179,
rs480575), GC (rs2282679), GCLM (rs3170633), HMOX1
(rs2071746, rs5995098), and NQO1 (rs1800566). Scores
representing participants’ allelic profiles were constructed
by summing these genetic variants, using the signs of the
coefficients of the Lasso penalization [28].
Statistical analyses
We evaluated the association between one standard
deviation (SD) increases in moving averages of BC and
PM2.5 exposure estimates (3 days-1 year) and several
HRV measures (HF, LF, LF:HF, and SDNN), using linear
mixed models with random intercepts and a compound-
symmetry covariance structure in a repeated measures
study. The outcome of interest was percent change in
HRV, which was calculated as [10(β*SD)-1]*100 %; 95 %
confidence intervals (CIs) were calculated as
[10[SD*(β±1.96*SE)]-1]*100 %, where SE is the standard
error associated with the regression coefficient β [10].
Measures of HRV were log-transformed to improve
normality and stabilize the variance.
All models controlled for potential confounders, which
were identified following a thorough literature search:
age, BMI, FBG, smoking history (current, former, or
never), current use of anti-hypertensive medications
(yes/no), room temperature at the time of ECG meas-
urement, season (indicated using the sine and cosine of
the date), MAP, and moving averages of outdoor
temperature corresponding to the pollutant exposure
measurement interval of interest (using both a linear
and quadratic term).
Because of previous research indicating potentially
susceptible subgroups [10, 15], we examined effect
modification of the association between 28 day exposure
to BC and HRV parameters by obesity (defined as BMI ≥
30 kg/m2; yes/no), hypertension (yes/no), diabetes (yes/
no) and oxidative stress allelic profile (high/low; dichoto-
mized based on median score) using separated linear
regression models. We also included multiplicative inter-
action terms in regression models to evaluate effect
modification. We conducted all analyses using SAS
versions 9.3 and 9.4.
Survivor bias
Because people who did not return for subsequent visits
are likely to have been less healthy than those who did,
this study, like all longitudinal cohorts, can suffer from a
dynamic selection bias. To counteract this, we used in-
verse probability weighting. Specifically, we modeled the
probability of returning for a visit based on variables
available at previous visits, including HRV measures.
The observations were given weights of one for the first
visit, the inverse of the probability of returning for the
second visit, and the product of the inverse of the prob-
ability of returning for the second visit times the inverse
of the probability of returning for the third visit, and so
on for subsequent visits.
Mordukhovich et al. Environmental Health  (2015) 14:87 Page 3 of 10
Results
Participants’ characteristics at baseline visit are reported
in Table 1. Briefly, at this initial examination, partici-
pants evaluated for the association between BC and
HRV presented with a mean age of 73.6 years; most
(71 %) were former or current smokers, 20 % were
diabetic and 25 % had a BMI > 30 kg/m2. Participants
evaluated for the association between PM2.5 and HRV
presented with a mean age of 75.2 years; most (70 %)
were former or current smokers, 21 % were diabetic and
26 % had a BMI > 30 kg/m2. We also present partici-
pants’ baseline HRV measures (HF, LF, SDNN, and the
LF:HF ratio) in Table 1.
Pollutant concentrations across all study visits and
averaging periods are reported in Table 2. For example,
for a 28 day moving average of BC exposure, we
observed a mean exposure level of 0.4 μg/m3 (SD: 0.2;
5th–95th percentiles: 0.2–0.8 μg/m3); for PM2.5, the cor-
responding values were 9.5 μg/m3 (SD: 2.5; 5th–95th
percentiles: 5.8–14.2 μg/m3). For a 3 day moving average
of BC exposure, we observed a mean exposure level of
0.4 μg/m3, with a standard deviation of 0.3. We report
Spearman correlation coefficients between selected ex-
posure measure durations (3, 14, 28 and 84 days, as well
as 1 year) for both BC and PM2.5 in Additional file 1:
Table S1. For BC, correlations between exposure
measurement periods were fairly high, ranging from
0.65 to 0.97. For PM2.5, correlations were somewhat
weaker, ranging from 0.25 to 0.87. The correlation be-
tween 28 day BC exposure and 1 year BC exposure
was r = 0.76, and the corresponding correlation for
PM2.5 was r = 0.53.
Associations between moving averages of BC and
PM2.5 exposures and HRV parameters are presented in
Table 3. We observed associations between increased
sub-chronic BC exposure and decreased HF, LF, and
SDNN, as well as an increased LF:HF ratio, though the
confidence intervals were somewhat imprecise and in
Table 1 Characteristics at baseline of study participants with







Age (years) 73.6 (7.0) 75.2 (6.4)
Body mass index (kg/m2) 28.1 (4.0) 27.9 (4.1)
≥ 30 kg/m2 (n [%]) 137 (25.4) 121 (25.5)
< 30 kg/m2 (n [%]) 403 (74.6) 354 (74.5)
Fasting blood glucose (n [%])
< 110 mg/dL 371 (68.7) 332 (69.9)
≥ 110 or <126 mg/dL 96 (17.8) 91 (19.2)
≥ 126 mg/dL 73 (13.5) 52 (11.0)
Smoking
Never smoker 156 (28.9) 143 (30.1)
Current smoker 22 (4.1) 14 (3.0)
Former smoker 362 (67.0) 318 (67.0)
Anti-hypertensive medicine use (n [%])
Yes 325 (60.2) 311 (65.5)
No 215 (39.8) 164 (34.5)
Season
Spring 135 (25.0) 112 (23.6)
Summer 109 (20.2) 120 (25.3)
Fall 166 (30.7) 144 (30.3)
Winter 130 (24.1) 99 (20.8)
Mean arterial pressure (mmHg) 92.6 (10.7) 87.9 (10.0)
Room temperature (°C) 24.1 (1.9) 23.3 (1.8)
Diabetes (n [%])
Yes 107 (19.8) 99 (20.8)
No 433 (80.2) 376 (79.2)
Oxidative stress gene score
Low 184 (42.0) 146 (38.4)
High 254 (58.0) 234 (61.6)
Heart rate variability
Log10HF, msec
2 1.9 (0.7) 2.0 (0.7)
Log10LF, msec
2 2.0 (0.6) 1.9 (0.6)
Log10SDNN, msec 1.5 (0.3) 1.5 (0.3)
Log10LF:HF 0.04 (0.5) −0.05 (0.5)
BC black carbon, PM2.5 particulate matter <2.5 μm in aerodynamic diameter
aNormative Aging Study (2000–2011)
bValues are mean (SD) or n (%)




N visits Mean (SD) 5th–95th percentiles IQR
BC (μg/m3)
3 days 1161 0.43 (0.29) 0.12–0.93 0.29
7 days 1161 0.44 (0.26) 0.14–0.85 0.28
14 days 1160 0.44 (0.25) 0.14–0.81 0.26
21 days 1153 0.44 (0.24) 0.14–0.81 0.26
28 days 1148 0.44 (0.24) 0.15–0.81 0.26
1 year 974 0.45 (0.17) 0.22–0.74 0.19
PM2.5 (μg/m3)
3 days 920 9.40 (4.48) 3.79–18.60 5.44
7 days 918 9.41 (3.32) 4.74–15.94 4.44
14 days 920 9.46 (2.91) 5.30–14.61 3.95
21 days 916 9.51 (2.67) 5.62–14.50 3.59
28 days 911 9.49 (2.53) 5.82–14.15 3.55
1 year 806 9.71 (1.36) 7.40–11.64 2.01
BC black carbon, IQR interquartile range, PM2.5 particulate matter <2.5 μm in
aerodynamic diameter, SD standard deviation
aStudy visits with information on BC spanned 2000 and 2011. Study visits with
information on PM2.5 spanned 2003 and 2011
Mordukhovich et al. Environmental Health  (2015) 14:87 Page 4 of 10
most cases spanned the null. This association was
slightly stronger when evaluating 28-day and 56-day
moving averages of exposure relative to other exposure
durations, and was strongest for HF in comparison to
other measures of HRV. For example, a 1 SD increase in
BC measured during the preceding 28 days was associ-
ated with a 2.3 % decrease in HF (95 % CI: −4.6, −0.02),
a 1 SD increase in 21 day BC exposure was associated
with a 2.2 % decrease in HF (95 % CI: −4.4, 0.1), and a 1
SD increase in 7 day BC exposure was associated with a
1.9 % decrease in HF (95 % CI: −4.3, 0.6). A 1 SD in-
crease in 28 day BC exposure was also associated with a
1.0 % decrease in LF (95 % CI: −3.0, 1.0), a 0.5 %
decrease in SDNN (95 % CI: −1.5, 0.4), and a 1.3 %
increase in the LF:HF ratio (95 % CI: −0.2, 2.8). When
evaluating long-term BC exposures of 1 year prior to
Table 3 Mixed linear effects models estimating percent changes in HRV measures according to one standard deviation increases in
BC and PM2.5 levelsa,b
Exposure duration HRV parameter BC PM2.5
% change 95 % CI % change 95 % CI
3 days HF −2.1 −4.8, 0.6 −35.5 −63.0, 12.5
LF −1.0 −3.3, 1.4 −31.7 −57.5, 9.5
SDNN −0.4 −1.5, 0.8 −11.5 −29.6, 11.4
Ratio (LF:HF) 1.1 −0.6, 2.9 6.5 −25.4, 52.0
7 days HF −1.9 −4.3, 0.6 4.3 −31.2, 58.2
LF −0.7 −2.8, 1.5 9.4 −23.4, 56.1
SDNN −0.4 −1.4, 0.6 3.1 −13.2, 22.4
Ratio (LF:HF) 1.1 −0.5, 2.7 4.4 20.1, 36.4
14 days HF −2.2 −4.5, 0.3 1.1 −30.5, 47.1
LF −0.9 −2.9, 1.2 15.6 −16.2, 59.4
SDNN −0.4 −1.4, 0.6 6.6 −8.7, 24.5
Ratio (LF:HF) 1.3 −0.3, 2.9 13.1 −10.8, 43.5
21 days HF −2.2 −4.4, 0.1 −6.8 −34.5, 32.6
LF −1.2 −3.2, 0.9 15.0 −15.0, 55.6
SDNN −0.6 −1.6, 0.4 6.8 −7.6, 23.5
Ratio (LF:HF) 1.1 −0.5, 2.7 21.6 −2.7, 51.9
28 days HF −2.3 −4.6, −0.02 −8.2 −34.8, 29.2
LF −1.0 −3.0, 1.0 22.4 −8.6, 64.1
SDNN −0.5 −1.5, 0.4 7.8 −6.3, 24.0
Ratio (LF:HF) 1.3 −0.2, 2.8 31.4 5.9, 63.0
56 days HF −2.3 −4.6, −0.1 −13.1 −34.6, 15.4
LF −1.0 −3.0, 1.0 11.2 −13.0, 42.0
SDNN −0.7 −1.6, 0.3 2.5 −8.9, 15.4
Ratio (LF:HF) 1.3 −0.2, 2.8 25.0 4.5, 49.6
84 days HF −2.0 −4.2, 0.2 −2.6 −24.3, 25.4
LF −0.9 −2.8, 1.1 16.1 −6.6, 44.1
SDNN −0.7 −1.6, 0.3 6.0 −4.5, 17.7
Ratio (LF:HF) 1.2 −0.3, 2.6 16.2 −1.0, 36.5
1 year HF −0.3 −2.1, 1.6 1.7 −14.6, 21.2
LF −0.2 −1.7, 1.4 23.6 6.0, 44.1
SDNN −0.1 −0.9, 0.7 7.0 −0.5, 15.1
Ratio (LF:HF) 0.04 −1.1, 1.2 21.0 8.6, 34.8
BC black carbon, HF high frequency, LF low frequency, PM2.5 particulate matter <2.5 μm in diameter, SD standard deviation, SDNN standard deviation of
normal-to-normal intervals
aSpecifically, we evaluated associations between percent change in HRV and 1 SD increases in BC (1161 visits) and PM2.5 (992 visits)
bStudy visits with information on BC spanned 2000 and 2011. Study visits with information on PM2.5 spanned 2003 and 2011
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study visit, results showed a similar pattern but were
attenuated greatly (Table 3). Moreover, when we in-
cluded 28 day and 1 year BC exposure in the same
model for HF, the magnitude of the association with
28 day BC increased, while the association with 1 year
BC changed direction (data not shown). Similarly,
effect estimates for 28 day BC were strengthened
when adjusting for BC exposure 1 day before the visit
(data not shown), indicating that short-term expo-
sures are not dominating the observed association
with sub-chronic BC.
We found some evidence of associations between
increased short-term PM2.5 exposure estimates and
decreases in HF, LF, and SDNN, as well as increased
LF:HF ratio (our results for a 3 day moving average
are reported in Table 3; data for 1 and 2 day averages
are not shown), though the associated confidence
intervals were very wide and many of the effect esti-
mates were not statistically significant. In addition,
the patterns of association we observed for shorter-
term exposures were inconsistent when evaluating
associations between modeled PM2.5 exposures reflect-
ing 7 day to 1 year moving averages and HF and
SDNN (Table 3). Associations between sub-chronic
and long-term PM2.5 and both LF and the LF:HF
ratio were consistently elevated and tended to be
strongest for longer-term exposures. For example, the
percent increase in the LF:HF ratio in relation to a 1
SD increase in PM2.5 was 13.1 % (95 % CI: −10.8,
43.5) for a 14 day moving average, 31.4 % (95 % CI:
5.9, 63.0) for a 28 day moving average, and 21.0 %
(95 % CI: 8.6, 34.8) for a 1 year average. The correspond-
ing increases for LF were 15.6 % (95 % CI: −16.2, 59.4),
22.4 % (95 % CI: −8.6, 64.1), and 23.6 % (95 % CI: 6.0,
44.1, respectively (Table 3).
Finally, associations between 28 day BC exposure esti-
mates and HF stratified by obesity, hypertension, dia-
betes, and oxidative stress genetic score are reported in
Table 4. We also examined interactions between
28 day BC and the aforementioned characteristics
with respect to other HRV measures (data not
shown). No multiplicative interaction terms rose to
the level of statistical significance and confidence
intervals were wide. Consistent with previous findings,
however, the decrease in HRV in relation to BC
exposure was greater among those with obesity or
diabetes. For example, a 1 SD increase in BC expos-
ure was associated with a 1.7 % decrease in HF (95 %
CI: −4.5, 1.2) among men with BMI <30, and a 3.5 %
decrease in HF among men with a BMI of 30 or
greater (95 % CI: −7.4, 0.5) (Table 4). BC exposure
was also associated with a greater increase in HF among
those with a lower oxidative stress genetic score. We
observed no consistent patterns for hypertension.
Discussion
We report positive associations between several mea-
sures of sub-chronic BC exposure, a marker of traffic
pollution, and decreased HRV in a cohort of elderly
men, although confidence intervals were wide and
mostly spanned the null. These findings are consistent
with many previous studies reporting associations
between short-term particulate pollution exposure and
decreased HRV [10, 14], which is predictive of increased
cardiovascular morbidity and mortality [12, 13], but
extend the literature to longer exposure measurement
periods, and demonstrate somewhat larger effect sizes
for those longer exposures. Longer-term exposures may
be of most interest when assessing risk for adverse
cardiovascular outcomes [19]. It is also notable that the
observed associations reflect not only short-term spikes
in particulate levels, but rather occur at particulate
pollutant levels that are consistently at or below EPA
standards. Our also extends the literature by using a
sophisticated modeling approach, rather than fixed mon-
itoring data, to predict individualized residential pollu-
tant exposures during 3, 7, 14, 21, 28, 56 and 84 days
and well as 1 year prior to each study visit [23, 25].
When evaluating BC exposures, we consistently found a
larger effect size for HF, a marker of parasympathetic
drive, than for LF. We also found some evidence of an
increased LF:HF ratio. Recent research suggests the
LF:HF ratio may be influenced primarily by parasympa-
thetic output and baroreflex function [29, 30].
We observed attenuated associations between HF and
1-year BC exposure, which changed direction upon
adjustment for 28-day BC exposure, suggesting the weak
Table 4 Modification of the association between a one
standard deviation increase in 28-day BC and percent
change in HFa
Characteristics % change 95 % CI
Oxidative stress genetic score < median −3.3 −7.4, 1.0
Oxidative stress genetic score > median −1.8 −4.9, 1.5
P for interaction 0.55
Not obese −1.7 −4.5, 1.2
Obese −3.5 −7.4, 0.5
P for interaction 0.64
No diabetes −2.1 −4.6, 0.4
Diabetes −4.6 −10.6, 1.8
P for interaction 0.51
No hypertension −2.2 −5.8, 1.5
Hypertension −2.2 −5.0, 0.8
P for interaction 0.60
BC black carbon, HF high frequency power, SD standard deviation
aWe evaluated effect modification of the association between a 1 SD increase
in the 28 day moving average of BC exposure and percent change in HF;
Normative Aging Study, 2000–2011
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association observed between 1 year BC and HRV was
explained by correlations with the shorter-term, sub-
chronic exposures rather than by the long-term expos-
ure. We did not observe a consistent pattern of associa-
tions between sub-chronic or long-term PM2.5 exposure
and HF. While studies consistently report associations
between short-term particulate pollution exposure and
reduced HF, especially among the elderly or those with
preexisting conditions [14, 16], very few have examined
exposure periods of greater than a few days [31, 32].
Hence, although long-term PM exposure is known to
have a stronger effect on cardiovascular mortality than
acute exposure [19], the effects of long-term or sub-
chronic particulate exposure on HF are unclear. Specific-
ally, to our knowledge, only two studies have examined
the association between long-term PM exposure (specific-
ally, PM <10 μm in aerodynamic diameter [PM10] levels
averaged over a 10 year period, among participants aged
50 and over) and HRV; they reported a null overall asso-
ciation between long-term PM10 and HRV, with re-
duced HRV observed among participants taking ACE
inhibitors or with a particular pro-inflammatory poly-
morphism [31, 32]. Ours is also the first study to
evaluate sub-chronic PM2.5 or BC exposure in relation
to HRV. Further studies are necessary to clarify the
effect of longer-term pollutant exposure on cardiac
autonomic control.
We report discrepant findings for BC and PM2.5. The
direction of results for modeled PM2.5 exposure 1, 2, or
3 days prior to the study visit are consistent with previ-
ous fixed monitoring studies from the NAS [10, 15] as
well as with our findings for sub-chronic BC exposure.
Air pollution was associated with decreased HF, LF, and
SDNN as well as an increased LF:HF ratio in these stud-
ies. In our study, associations between longer-term
PM2.5 levels and HF measures were inconsistent, and
PM2.5 was related to an increase in LF, which is incon-
sistent with previous studies among elderly people, but
is sometimes seen among younger subjects [33, 34]. We
also observed a consistent, though imprecise, positive
association between PM2.5 exposure and an increased
LF:HF ratio, which was similar to our results for BC and
was in general strongest for exposures measured over
longer time periods.
Although BC is a component of PM, the source profiles
of BC and PM2.5 differ. BC is a marker of traffic pollution,
especially diesel exhaust and, in Boston, home heating oil
[35], whereas these sources contribute to a minority of
PM2.5 levels [36, 37]. The effects of different particle com-
ponents or sources on health outcomes may vary, and
emerging evidence suggests that traffic pollution may be
especially important with regard to cardiovascular disease
[38]. It should be noted that BC and PM2.5 estimates were
derived from different exposure models; the differences in
results for BC and PM2.5 and for shorter and longer-term
PM2.5 do not have a clear biological basis and could also
be due to a difference in modeling approach. We also note
that that confidence intervals for the PM2.5 estimates were
very wide, which increases the likelihood some of our
results may be due to chance. While we cannot be sure of
an underlying mechanism, one possible reason that we
observed stronger associations for sub-chronic rather than
long-term BC could be that HRV fluctuates based on a
variety of short-term stimuli and this might overpower the
effect of air pollution exposure over the course of a year,
but not a shorter period of 1–2 months.
Potential mechanisms underlying possible associations
between BC or PM2.5 and HRV include a particulate-
induced increase in pulmonary oxidative stress, which
can in turn induce proinflammatory cytokines [39], in-
crease extracellular calcium influx [40], inactivate nitric
oxide [41], and lead to greater parasympathetic than
sympathetic nervous system withdrawal [19]. The result
of these changes is an increased risk of cardiovascular
morbidity and mortality, including ventricular arrhyth-
mias and myocardial infarction [19].
We did not observe strong evidence of effect modifica-
tion by obesity, hypertension, diabetes, or oxidative stress
allelic profile, which may have been due to the low preci-
sion of stratified effect estimates. While not rising to the
level of statistical significance, associations between BC
exposure and HRV were somewhat stronger among men
with obesity and diabetes, which is notable mainly because
of similarity to previous findings [10, 15]. One explanation
for these findings is that diabetes and obesity are
themselves associated with reduced autonomic func-
tion [42–44], possibly rendering diabetics and those
with a BMI over 30 kg/m2 more susceptible to the ef-
fects of particles on this same endpoint. We observed
a stronger reduction in HF relative to BC exposure
among men with lower oxidative stress genetic scores,
which was unexpected. It should be noted that we
did not have sufficient power to examine effect modi-
fication in an optimal way, and larger studies will be
needed in the future in order to examine the possibil-
ity of susceptible subgroups more thoroughly, and to
obtain more precise and stable effect estimates than
we were able to calculate.
We acknowledge several limitations of our study.
These include potential exposure misclassification of
pollutant estimates, which could affect precision and
potential bias effect size [45]. This possibility is standard
to environmental epidemiology studies, and our use of
sophisticated, spatially and temporally resolved models
to estimate individualized residential pollutant exposures
has likely reduced misclassification relative to fixed
monitoring studies. The exposure model also did not ac-
count for indoor pollutant levels or residential indoor
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temperatures, and did not estimate the rate at which
outdoor pollutants may penetrate indoors, though
studies have shown that the contribution of outdoor air
pollution to indoor pollutant levels [46, 47] and to moni-
tored personal exposures, including in the Boston area
[48], is fairly high.
Our study did not adjust for multiple comparisons.
We chose to qualitatively examine the pattern of results
instead. As we noted earlier, the confidence intervals
associated with most of the observed effect estimates
were wide, especially when evaluating PM2.5, and only a
handful of effect estimates were statistically significant.
Our findings are consistent with the greater literature on
this subject, which adds plausibility to the pattern of
associations we observed. Larger studies with greater
statistical power will be needed to confirm and expand
on our initial findings.
Ideally, we would have compared results for PM2.5 and
BC estimated from the same exposure models. However,
this was not possible in our study because PM2.5 levels
were derived from AOD measurements, which do not
capture the BC component of PM, and many of the BC
measurements were obtained from ethylometers, which
measured BC but not overall PM. Thus, we cannot rule
out that differences in our findings for BC and fine PM
could be due to differing modeling approaches.
The changes in HRV that we observed in this study do
not rise to a level of clinical concern, but shifting the dis-
tribution of HRV measures may be of public health con-
cern because of changes among ‘borderline’ individuals.
Furthermore, PM2.5 levels in the Boston area are generally
below EPA air quality standards, whereas other areas may
have consistently higher pollutant levels which could
affect HRV to a greater extent. Finally, part of our goal
was to identify mechanisms mediating the association be-
tween particulate pollutant exposure and adverse cardio-
vascular outcomes, and these results, if confirmed, suggest
that effects on HRV may be part of that pathway.
Our study population is comprised of elderly men, the
vast majority of whom are retired, which is both a limita-
tion and strength. Participants’ estimated residential expo-
sures are likely to reflect the great majority of their total
exposure burden, which is a strength in terms of exposure
assessment, but results may not be generalizable to other
(non-elderly, non-White, female) segments of the popula-
tion. We examined this association within an elderly co-
hort because the elderly comprise a large, susceptible sub-
population with respect to cardiovascular ailments and
health effects of particle exposure. Finally, the sampling
rate we used when measuring HRV is still clinically appro-
priate, but is lower that what is currently preferred for re-
search purposes. This could lead to some non-differential
measurement error and a consequent reduction in statis-
tical power and bias towards the null.
Strengths of our study include access to a large,
general population cohort with extensive and repeated
information regarding pollutant exposures, potential
confounders and effect modifiers, and HRV data from
multiple study visits. While most air pollution studies
examine short-term exposures, longer-term exposures
may be of most interest when assessing risk for chronic
disease and dysfunction. Hence, an additional strength of
our study was the reconstruction of participants’ sub-
chronic and long-term BC and PM2.5 exposures using
comprehensive models. Our use of spatially resolved resi-
dential exposure measurements is another important
strength, especially for BC, since traffic exposures can vary
significantly within a small geographic distance [25].
Conclusions
In our study of particulate air pollution exposure and
HRV, we report a pattern of associations between sub-
chronic BC exposure estimates and decreased HF, LF, and
SDNN, as well as increased LF:HF ratio. Although our
limited statistical power led to wide confidence intervals
that often spanned the null, our findings were similar to
previous studies of short-term exposure in the NAS [10]
and other study populations [14]. Long-term BC exposure
was not linked to HRV after adjustment for sub-chronic
exposure levels. We report discrepant findings for BC and
PM2.5, as sub-chronic and long-term PM2.5 exposure
estimates were associated with an increased LF and LF:HF
ratio, but not other changes in HRV (HF or SDNN). HRV
may mediate associations between particulate exposures
and adverse cardiovascular outcomes, and assessing
longer-term exposures is important to understanding ef-
fects of air pollution on chronic disease and dysfunction.
Future high-powered studies should therefore further
evaluate associations between sub-chronic or long-term
pollutant exposures and HRV, including with respect to
identifying potentially susceptible subpopulations.
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